Author: Cooper, Rachel S.; Kowalczuk, Aleksandra; Wilkie, Gwen; Vickers, Mark A.; Turner, Marc L.; Campbell, John D. M.; Fraser, Alasdair R.
Title: Cytometric analysis of T cell phenotype using cytokine profiling for improved manufacturing of an EBVâ€specific T cell therapy Cord-id: nly4jksa Document date: 2021_7_14
ID: nly4jksa
Snippet: Adoptive immunotherapy using Epstein–Barr Virus (EBV)â€specific T cells is a potentially curative treatment for patients with EBVâ€related malignancies where other clinical options have proved ineffective. We describe improved good manufacturing practice (GMP)â€compliant culture and analysis processes for conventional lymphoblastoid cell line (LCL)â€driven EBVâ€specific T cell manufacture, and describe an improved phenotyping approach for analysing T cell products. We optimized the curren
Document: Adoptive immunotherapy using Epstein–Barr Virus (EBV)â€specific T cells is a potentially curative treatment for patients with EBVâ€related malignancies where other clinical options have proved ineffective. We describe improved good manufacturing practice (GMP)â€compliant culture and analysis processes for conventional lymphoblastoid cell line (LCL)â€driven EBVâ€specific T cell manufacture, and describe an improved phenotyping approach for analysing T cell products. We optimized the current LCLâ€mediated clinical manufacture of EBVâ€specific T cells to establish an improved process using xenoproteinâ€free GMPâ€compliant reagents throughout, and compared resulting products with our previous banked T cell clinical therapy. We assessed effects of changes to LCL:T cell ratio in T cell expansion, and developed a robust flow cytometric marker panel covering T cell memory, activation, differentiation and intracellular cytokine release to characterize T cells more effectively. These data were analysed using a tâ€stochastic neighbour embedding (tâ€SNE) algorithm. The optimized GMPâ€compliant process resulted in reduced cell processing time and improved retention and expansion of central memory T cells. Multiâ€parameter flow cytometry determined the optimal protocol for LCL stimulation and expansion of T cells and demonstrated that cytokine profiling using interleukin (IL)â€2, tumour necrosis factor (TNF)â€Î± and interferon (IFN)â€Î³ was able to determine the differentiation status of T cells throughout culture and in the final product. We show that fully GMPâ€compliant closedâ€process culture of LCLâ€mediated EBVâ€specific T cells is feasible, and profiling of T cells through cytokine expression gives improved characterization of start material, inâ€process culture conditions and final product. Visualization of the complex multiâ€parameter flow cytometric data can be simplified using tâ€SNE analysis.
Search related documents:
Co phrase search for related documents- activation status and acute infection: 1, 2, 3, 4, 5
- activation status differentiation and acute infection: 1, 2
- acute infection and adoptive immunotherapy: 1
- acute infection and low high population: 1, 2
- acute infection and low intensity: 1, 2
Co phrase search for related documents, hyperlinks ordered by date